Successful Usage of Combination Biologic Therapy with Etanercept and Actemra for the Treatment of Tnf Inhibitor Failure Patients with Rheumatoid Arthritis: A Report of 2 Cases - Juniper Publishers
juniperpublishers (noreply@blogger.com)
Arthritis & Bone Research - Juniper Publishers Abstract In the treatment of patients with rheumatoid
arthritis with anti-tumour necrosis factor therapy, it is not uncommon
for some patients to be unresponsive or relapse with treatment. We
report the successful usage of combination biologic therapy with
etanercept and tocilizumab in two patients with moderately severe
rheumatoid arthritis who failed etanercept therapy. This is the first
report of combination anti-tumour necrosis factor and